[{"Assets_0_Q2_USD":61839000.0,"CommonStockSharesOutstanding_0_Q2_shares":36992000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-25133000.0,"NetIncomeLoss_2_Q2_USD":-26441000.0,"NetIncomeLoss_1_Q2_USD":-13436000.0,"StockholdersEquity_0_Q2_USD":48232000.0,"Ticker":"VSTM","CIK":"1526119","name":"VERASTEM, INC.","OfficialName":"Verastem Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"309307156.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170808"}]